• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤干细胞样细胞增强细胞毒性淋巴细胞对胶质瘤分化细胞的杀伤作用。

Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.

作者信息

Bassoy Esen Yonca, Chiusolo Valentina, Jacquemin Guillaume, Riccadonna Cristina, Walker Paul R, Martinvalet Denis

机构信息

Department of Cell Physiology and Metabolism University of Geneva, 1211, Geneva, Switzerland.

Geneva University Hospitals and University of Geneva, Centre of Oncology, 1211, Geneva, Switzerland.

出版信息

PLoS One. 2016 Apr 13;11(4):e0153433. doi: 10.1371/journal.pone.0153433. eCollection 2016.

DOI:10.1371/journal.pone.0153433
PMID:27073883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4830556/
Abstract

Glioblastoma multiforme, the most aggressive primary brain tumor, is maintained by a subpopulation of glioma cells with self-renewal properties that are able to recapitulate the entire tumor even after surgical resection or chemo-radiotherapy. This typifies the vast heterogeneity of this tumor with the two extremes represented on one end by the glioma stemlike cells (GSC) and on the other by the glioma differentiated cells (GDC). Interestingly, GSC are more sensitive to immune effector cells than the GDC counterpart. However, how GSC impact on the killing on the GDC and vice versa is not clear. Using a newly developed cytotoxicity assay allowing to simultaneously monitor cytotoxic lymphocytes-mediated killing of GSC and GDC, we found that although GSC were always better killed and that their presence enhanced the killing of GDC. In contrast, an excess of GDC had a mild protective effect on the killing of GSC, depending on the CTL type. Overall, our results suggest that during combination therapy, immunotherapy would be the most effective after prior treatment with conventional therapies.

摘要

多形性胶质母细胞瘤是最具侵袭性的原发性脑肿瘤,由具有自我更新特性的胶质瘤细胞亚群维持,即使在手术切除或放化疗后,这些细胞仍能重现整个肿瘤。这体现了该肿瘤的巨大异质性,其两个极端,一端是胶质瘤干细胞(GSC),另一端是胶质瘤分化细胞(GDC)。有趣的是,GSC比其对应的GDC对免疫效应细胞更敏感。然而,GSC如何影响对GDC的杀伤,反之亦然,目前尚不清楚。使用一种新开发的细胞毒性检测方法,能够同时监测细胞毒性淋巴细胞介导的对GSC和GDC的杀伤作用,我们发现尽管GSC总是更容易被杀伤,并且它们的存在增强了对GDC的杀伤。相反,过量的GDC对GSC的杀伤有轻微的保护作用,这取决于CTL的类型。总体而言,我们的结果表明,在联合治疗期间,免疫疗法在先接受传统疗法治疗后将是最有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/e919b81a60ed/pone.0153433.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/591f4190a43a/pone.0153433.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/768192e9f086/pone.0153433.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/d74af536b610/pone.0153433.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/4fa65afb2704/pone.0153433.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/e919b81a60ed/pone.0153433.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/591f4190a43a/pone.0153433.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/768192e9f086/pone.0153433.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/d74af536b610/pone.0153433.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/4fa65afb2704/pone.0153433.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/841d/4830556/e919b81a60ed/pone.0153433.g005.jpg

相似文献

1
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.胶质瘤干细胞样细胞增强细胞毒性淋巴细胞对胶质瘤分化细胞的杀伤作用。
PLoS One. 2016 Apr 13;11(4):e0153433. doi: 10.1371/journal.pone.0153433. eCollection 2016.
2
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.ABTC-0904:在 GBM 中靶向神经胶质瘤干细胞: hedgehog 通路抑制剂 GDC-0449 的 0/2 期研究。
J Neurooncol. 2023 Jan;161(1):33-43. doi: 10.1007/s11060-022-04193-3. Epub 2022 Dec 29.
3
Immunotherapy targeting glioma stem cells--insights and perspectives.针对神经胶质瘤干细胞的免疫疗法——见解与展望。
Expert Opin Biol Ther. 2012 Feb;12(2):165-78. doi: 10.1517/14712598.2012.648180. Epub 2011 Dec 26.
4
Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.紫檀芪通过调节 GRP78/miR-205 轴抑制耐辐射脑胶质瘤干细胞。
J Nutr Biochem. 2015 May;26(5):466-75. doi: 10.1016/j.jnutbio.2014.11.015. Epub 2015 Jan 19.
5
Establishment of a human glioblastoma stemlike brainstem rodent tumor model.人胶质母细胞瘤干细胞样脑干啮齿动物肿瘤模型的建立。
J Neurosurg Pediatr. 2010 Jul;6(1):92-7. doi: 10.3171/2010.3.PEDS09366.
6
Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells.从表达 IL13Rα2 的神经胶质瘤中分离出的类肿瘤起始细胞可被 IL13-zetakine 重定向的 T 细胞靶向和杀伤。
Clin Cancer Res. 2012 Apr 15;18(8):2199-209. doi: 10.1158/1078-0432.CCR-11-1669. Epub 2012 Mar 8.
7
Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.异质性胶质瘤干细胞群体自我更新中幂律生长的发现。
PLoS One. 2015 Aug 18;10(8):e0135760. doi: 10.1371/journal.pone.0135760. eCollection 2015.
8
Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.胶质瘤干细胞在伴有恶性进展的复发性肿瘤中比在原发性肿瘤中更具侵袭性,并且二者都能在体外长期维持。
BMC Cancer. 2008 Oct 22;8:304. doi: 10.1186/1471-2407-8-304.
9
Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.舒林酸诱导脑胶质瘤干细胞分化,使其对氧化应激更敏感。
Neoplasma. 2018 Mar 14;65(3):376-388. doi: 10.4149/neo_2018_170404N245.
10
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.地西他滨治疗胶质瘤起始细胞可增强免疫识别与杀伤作用。
PLoS One. 2016 Aug 31;11(8):e0162105. doi: 10.1371/journal.pone.0162105. eCollection 2016.

引用本文的文献

1
Non-target Genes Regulate miRNAs-Mediated Migration Steering of Colorectal Carcinoma.非靶基因调控微小RNA介导的结直肠癌迁移导向
Pathol Oncol Res. 2019 Apr;25(2):559-566. doi: 10.1007/s12253-018-0502-9. Epub 2018 Oct 25.
2
The role of the mitochondria and the endoplasmic reticulum contact sites in the development of the immune responses.线粒体和内质网接触点在免疫反应发展中的作用。
Cell Death Dis. 2018 Feb 28;9(3):336. doi: 10.1038/s41419-017-0237-7.
3
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.

本文引用的文献

1
Consensus nomenclature for CD8 T cell phenotypes in cancer.癌症中CD8 T细胞表型的共识命名法。
Oncoimmunology. 2015 Feb 25;4(4):e998538. doi: 10.1080/2162402X.2014.998538. eCollection 2015 Apr.
2
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.新型穿膜肽基疫苗诱导强烈的 CD4+ 和 CD8+ T 细胞介导的抗肿瘤免疫。
Cancer Res. 2015 Aug 1;75(15):3020-31. doi: 10.1158/0008-5472.CAN-14-3017. Epub 2015 Jun 26.
3
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
神经胶质瘤干细胞样细胞中的NKG2D配体:原位和体外表达
Histochem Cell Biol. 2018 Mar;149(3):219-233. doi: 10.1007/s00418-018-1633-5. Epub 2018 Jan 22.
4
ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.内质网-线粒体接触调控胶质瘤干细胞样细胞的表面聚糖表达及对杀伤性淋巴细胞的敏感性。
EMBO J. 2017 Jun 1;36(11):1493-1512. doi: 10.15252/embj.201695429. Epub 2017 Mar 10.
5
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.地西他滨治疗胶质瘤起始细胞可增强免疫识别与杀伤作用。
PLoS One. 2016 Aug 31;11(8):e0162105. doi: 10.1371/journal.pone.0162105. eCollection 2016.
胶质瘤干细胞在化疗耐药和多形性胶质母细胞瘤复发中的作用。
Expert Rev Neurother. 2015;15(7):741-52. doi: 10.1586/14737175.2015.1051968. Epub 2015 May 31.
4
Clinical value of CD133 and nestin in patients with glioma: a population-based study.CD133和巢蛋白在神经胶质瘤患者中的临床价值:一项基于人群的研究。
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3739-51. eCollection 2014.
5
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment.乳腺癌干细胞依赖发酵性糖酵解,且对2-脱氧葡萄糖治疗敏感。
Cell Death Dis. 2014 Jul 17;5(7):e1336. doi: 10.1038/cddis.2014.285.
6
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.单细胞 RNA 测序凸显原发性脑胶质瘤肿瘤内异质性。
Science. 2014 Jun 20;344(6190):1396-401. doi: 10.1126/science.1254257. Epub 2014 Jun 12.
7
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing.通过下一代测序鉴定Pmel-1 TCR α和β转基因的基因组插入位点。
PLoS One. 2014 May 14;9(5):e96650. doi: 10.1371/journal.pone.0096650. eCollection 2014.
8
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.重建和重编程神经胶质瘤干细胞的肿瘤增殖潜能。
Cell. 2014 Apr 24;157(3):580-94. doi: 10.1016/j.cell.2014.02.030. Epub 2014 Apr 10.
9
Evolution of the cancer stem cell model.癌症干细胞模型的演变。
Cell Stem Cell. 2014 Mar 6;14(3):275-91. doi: 10.1016/j.stem.2014.02.006.
10
Prognostic value of Musashi-1 in gliomas.Musashi-1 在脑胶质瘤中的预后价值。
J Neurooncol. 2013 Dec;115(3):453-61. doi: 10.1007/s11060-013-1246-8. Epub 2013 Sep 21.